BV vs IVPR
BrightView Holdings, Inc. and Inspire Veterinary Partners, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BV | IVPR |
|---|---|---|
| Revenue | $2.7B | $16.6M |
| Net income | $56.0M | $-14.3M |
| Gross margin | 23.3% | — |
| Net margin | 2.1% | −86.0% |
| Return on equity | 4.4% | −3687.1% |
| Diluted EPS | $0.13 | — |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $37.6M | $-10.2M |
| Equity | $1.3B | $1.6M |
| Net debt / equity | 0.55× | 7.34× |
| Current ratio | 1.30× | 0.25× |
| Revenue CAGR 5y | 2.6% | — |
| Profit CAGR 5y | — | — |
BV bills 161.1× the revenue of IVPR, and IVPR closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
3 years side by side
| Fiscal year | BV | IVPR |
|---|---|---|
| FY2024 | $2.8B | $16.6M |
| FY2023 | $2.8B | $16.7M |
| FY2022 | $2.8B | $9.8M |
Net income by year
Bottom line
| Fiscal year | BV | IVPR |
|---|---|---|
| FY2024 | $66.4M | $-14.3M |
| FY2023 | $-7.7M | $-14.8M |
| FY2022 | $14.0M | $-4.9M |
Advertisement
AdSense · Rectangle 336×280